Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer

Cancer Immunology, Immunotherapy

Volumn 60, Issue 10, 2011, Pages 1497-1502

  Zhong, Runbo ^a   Teng, Jiajun ^a   Han, Baohui ^a   Zhong, Hua ^a  

^a SHANGHAI CHEST HOSPITAL   (China)

Author keywords

Chemoimmunotherapy; Cytokine induced killer cell; Dendritic cell; Non small cell lung cancer

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CISPLATIN; DENDRITIC CELL VACCINE; NAVELBINE;

ACNE; ADULT; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFICACY; DRUG ERUPTION; DRUG FEVER; DRUG POTENTIATION; DRUG TOLERABILITY; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PRURITUS; SKIN TOXICITY; SURVIVAL TIME; TREATMENT DURATION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CANCER VACCINES; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; CYTOKINE-INDUCED KILLER CELLS; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNOTHERAPY; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PLATINUM COMPOUNDS; VINBLASTINE;

EID: 80054110411     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-011-1060-0     Document Type: Article

References (15)

1. A Jemal RC Tivare T Murray A Ghafoor A Samuels E Ward, et al. 2004 Cancer statistics CA Cancer J Clin 54 8 29 14974761 10.3322/canjclin.54.1.8
2. JM Sun JO Park YW Won JH Kim J Yun J Lee YH Park JS Ahn MJ Ahn K Park 2010 Who are less likely to receive subsequent chemotherapy beyond first-line therapy for advanced non-small cell lung cancer? Implications for selection of patients for maintenance therapy J Thorac Oncol 5 4 540 545 20195170 10.1097/JTO.0b013e3181d3504d
3. JH Schiller D Harrington CP Belani C Langer A Sandler J Krook, et al. 2002 Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer N Engl J Med 346 92 98 11784875 10.1056/NEJMoa011954 1:CAS:528: DC%2BD38Xkt1OlsQ%3D%3D (Pubitemid 34438899)
4. RJ Kelly JL Gulley G Giaccone 2010 Targeting the immune system in non-small-cell lung cancer: bridging the gap between promising concept and therapeutic reality Clin Lung Cancer 11 4 228 237 20630824 10.3816/CLC.2010.n. 029 1:CAS:528:DC%2BC3cXpvVegs78%3D Review
5. C Gérard C Debruyne 2009 Immunotherapy in the landscape of new targeted treatments for non-small cell lung cancer Mol Oncol 3 5-6 409 424 19846354 10.1016/j.molonc.2009.09.001 [Epub 10 Sep 2009. (Review)]
6. LD Cranmer KT Trevor EM Hersh 2004 Clinical applications of dendritic cell vaccination in the treatment of cancer Cancer Immunol Immunother 53 275 306 14648069 10.1007/s00262-003-0432-5 (Pubitemid 38392306)
7. S Mocellin S Mandruzzato V Bronte M Lise D Nitti 2004 Part I. Vaccines for solid tumours Lancet Oncol 5 681 689 15522656 10.1016/S1470-2045(04)01610-9 1:CAS:528:DC%2BD2cXptFKktb8%3D (Pubitemid 40267853)
8. FO Nestle A Farkas C Conrad 2005 Dendritic-cell-based therapeutic vaccination against cancer Curr Opin Immunol 17 163 169 15766676 10.1016/j.coi.2005.02.003 1:CAS:528:DC%2BD2MXit1ChtL4%3D (Pubitemid 40343103)
9. S Ming Z Bing T Zi-Rong, et al. 2004 Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma World J Gastroenterol 10 8 1146 1151
10. L Hui W Changli Y Jinpu, et al. 2009 Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery Cytotherapy 11 8 1076 1083 10.3109/14653240903121252
11. EA Susan RG Jose S Martin, et al. 1998 Dendritic cells pulsed with CEA peptide induced CEA-specific CTL with restricted TCR repertoire J Immunother 21 1 17 26 10.1097/00002371-199801000-00002 (Pubitemid 28044832)
12. A Marten C Ziske B Schottker, et al. 2001 Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations J Immunother 24 6 502 510 11759073 10.1097/00002371-200111000-00007 1:CAS:528:DC%2BD38Xkt1Gm (Pubitemid 33104869)
13. R Kaneno GV Shurin IL Tourkova MR Shurin 2009 Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrations J Transl Med 7 58 19591684 10.1186/1479-5876-7-58
14. GV Shurin IL Tourkova R Kaneno MR Shurin 2009 Chemotherapeutic agents in noncytotoxic concentrations increase antigen presentation by dendritic cells via an IL-12-dependent mechanism J Immunol 183 1 137 144 19535620 10.4049/jimmunol.0900734 1:CAS:528:DC%2BD1MXnsVOrtb8%3D E pub 2009 Jun 17
15. H Zhong B Han IL Tourkova A Lokshin A Rosenbloom MR Shurin GV Shurin 2007 Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth Clin Cancer Res 13 18 Pt 1 5455 5462 17875775 10.1158/1078-0432.CCR-07-0517 1:CAS:528:DC%2BD2sXhtVCitL3M (Pubitemid 47510373)